Today’s top gainers include the company Mylan N.V. (NASDAQ:MYL) which is in the industry Drugs – Generic, gaining -1.29% today. In the last week its performance is -3.25%, and -9.17% for the past quarter. Currently, Mylan N.V., MYL has a target price of 49.67, so today’s gain of -1.29% is a significant step towards its target price. The GAP today is therefore 0.28%.
Mylan N.V. (NASDAQ:MYL), has a market cap of 20.7 B, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 71.40%.
At the current price of 38.15, it has a dividend yield of *TBA, and its target price is 49.67. This is with a profit margin of 4.60%, and total debt/equity of 1.29. Mylan N.V. (NASDAQ:MYL) has a P/E of 38, as well as a forward P/E of 6.72.
With a current EPS of 1, and a forecasted EPS growth for next year at 9.06%,Mylan N.V. (NASDAQ:MYL) has had a EPS growth for the past five years at -5.50%. For the next five years EPS growth is projected to be 8.80%.
Performance for the year is -9.25%. Since its IPO date on 12/18/1987, the total performance to date is 0.00%.
Volume today for Mylan N.V. (NASDAQ:MYL), is 4891098, while its average volume is 5817.7. Whilst the total gain today was -1.29%, it did have a day high of -13.06%.
Volatility for this week has been at 1.76%, and 2.45% for the month. The 52-week low for Mylan N.V., MYL has been 13.54%, while the 52-week-high has reached -24.31%.
Looking at its return of investments, which is 3.90%, and its return on assets is 1.60%. Mylan N.V. (NASDAQ:MYL) has an operating margin of 6.90%. With a sales growth of 24.10% quarter over quarter. Bearing in mind that Mylan N.V., MYL is in the sector Healthcare, its long-term debt/equity is 1.26, and has a current ratio of 1.6 and 1 for quick ratio.
So what is the value of Mylan N.V.? Well its PEG is 4.32, and the P/S is 1.78, along with a P/B of 1.75. Meanwhile it has a p/cash of 24.